Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Abs. Returns |
---|---|---|---|---|
One Week | 2025-06-13 | ₹1,000.00 | ₹980.19 |
-1.98 %
|
Two Week | 2025-06-05 | ₹1,000.00 | ₹995.61 |
-0.44 %
|
One Month | 2025-05-21 | ₹1,000.00 | ₹1,008.36 |
0.84 %
|
Three Months | 2025-03-24 | ₹3,000.00 | ₹3,075.87 |
2.53 %
|
Six Months | 2024-12-23 | ₹6,000.00 | ₹6,202.51 |
3.38 %
|
One Year | 2024-06-20 | ₹12,000.00 | ₹12,675.06 |
5.63 %
|
Three Year | 2022-06-21 | ₹36,000.00 | ₹54,994.79 |
52.76 %
|
Five Year | 2020-06-22 | ₹60,000.00 | ₹106,637.05 |
77.73 %
|
Since Inception | 2018-07-13 | ₹85,000.00 | ₹198,755.08 |
133.83 %
|
Company Name | Sector | Sector Type | Nav(in %) |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Equity | 12.66 |
Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 9.66 |
Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 9.03 |
Cipla Ltd. | Pharmaceuticals & Biotechnology | Equity | 7.85 |
Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Equity | 6.34 |
Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 4.12 |
Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Equity | 4.01 |
Lupin Ltd. | Pharmaceuticals & Biotechnology | Equity | 3.98 |
Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Equity | 3.95 |
Syngene International Ltd. | Healthcare Services | Equity | 2.46 |
Pfizer Ltd. | Pharmaceuticals & Biotechnology | Equity | 2.27 |
Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.99 |
Apollo Hospitals Enterprise Ltd. | Healthcare Services | Equity | 1.79 |
Medplus Health Services Ltd | Retailing | Equity | 1.64 |
Mankind Pharma Ltd | Pharmaceuticals & Biotechnology | Equity | 1.62 |
Biocon Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.62 |
Shilpa Medicare Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.58 |
Sagility India Ltd | It - Services | Equity | 1.44 |
Thyrocare Technologies Ltd. | Healthcare Services | Equity | 1.42 |
Advanced Enzyme Technologies Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.42 |
Windlas Biotech Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.42 |
Medi Assist Healthcare Services Ltd | Insurance | Equity | 1.36 |
Aarti Drugs Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.28 |
Fine Organic Industries Ltd. | Chemicals & Petrochemicals | Equity | 1.28 |
Star Health & Allied Insurance | Insurance | Equity | 1.27 |
Sun Pharma Advanced Research Co. Ltd | Pharmaceuticals & Biotechnology | Equity | 1.16 |
Yatharth Hospital & Trauma Care Services Pvt Ltd | Healthcare Services | Equity | 1.07 |
Sanofi Consumer Healthcare India Ltd | Pharmaceuticals & Biotechnology | Equity | 1.01 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.00 |
Aarti Industries Ltd. | Chemicals & Petrochemicals | Equity | 0.98 |
FDC Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.95 |
Procter & Gamble Health Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.81 |
Astrazeneca Pharma India Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.80 |
Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.72 |
Senores Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Equity | 0.61 |
Unichem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.26 |
Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Equity | 0.14 |
Laxmi Organic Industries Ltd. | Chemicals & Petrochemicals | Equity | 0.01 |
TREPS | - | Debt | 2.90 |
Cash Margin - Derivatives | - | Debt | 0.15 |
Net Current Assets | - | Debt | -0.04 |
India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.
Lock-in times for various investment types
Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.
There are two different types of residual maturity.
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Axis Innovation Fund - Regular Plan - Growth |
9.98%
|
27.76%
|
14.42%
|
Canara Robeco Consumer Trends Fund - Regular Plan - Growth |
9.95%
|
34.58%
|
16.44%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
BARODA BNP PARIBAS INDIA CONSUMPTION FUND - REGULAR PLAN - GROWTH |
9.90%
|
31.87%
|
18.46%
|
Aditya Birla Sun Life India Reforms Fund - Growth-Regular Plan |
9.88%
|
18.78%
|
8.95%
|
Bajaj Finserv Banking and PSU Fund - Regular Plan - Growth |
9.60%
|
6.82%
|
9.12%
|
LIC MF Banking and PSU Fund - Regular Plan - Growth |
9.52%
|
11.08%
|
7.19%
|
NIPPON INDIA QUANT FUND - INSTITUTIONAL PLAN - GROWTH |
9.51%
|
2.81%
|
3.05%
|
Mirae Asset Banking and PSU Fund - Regular Plan |
9.47%
|
11.15%
|
5.56%
|
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
ICICI Prudential Dividend Yield Equity Fund - Growth |
9.97%
|
42.99%
|
16.10%
|
ICICI Prudential Credit Risk Fund - Growth |
9.66%
|
12.22%
|
8.28%
|
ICICI Prudential Medium Term Bond Fund - Growth |
9.65%
|
12.20%
|
7.51%
|
ICICI Prudential Debt Management Fund (FOF) - Growth |
9.62%
|
12.41%
|
7.26%
|
ICICI Prudential Capital Protection Oriented Fund SeriesXII Plan C 1270 Days-Cumulative |
9.57%
|
9.79%
|
6.10%
|
ICICI Prudential Corporate Bond Fund Retail Growth |
9.53%
|
11.81%
|
7.87%
|
ICICI Prudential Nifty SDL Sep 2027 Index Fund - Growth |
9.49%
|
12.24%
|
6.70%
|
ICICI Prudential Short Term Fund - Institutional Cumulative Option |
9.45%
|
11.28%
|
8.31%
|
ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund Growth |
9.34%
|
11.84%
|
5.95%
|
ICICI Prudential Corporate Bond Fund - Growth |
9.32%
|
12.24%
|
7.16%
|
Interested in exploring more about JezzMoney Mutual Fund Distributors Software? Submit the form, and we will respond quickly.